These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 6297337)

  • 21. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine.
    Pensaert MB; Vandeputte J; Andries K
    Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
    Vannier P
    Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vaccination on lesion development in pseudorabies virus-challenged swine.
    Alva-Valdes R; Glock RD; Kluge JP; Keune CM
    Am J Vet Res; 1983 Apr; 44(4):588-95. PubMed ID: 6307084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent studies on Aujesky's dissease in pigs and cattle (author's transl)].
    de Leeuw PW; Tiessink JW
    Tijdschr Diergeneeskd; 1980 Sep; 105(17):689-94. PubMed ID: 6252655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).
    Biront P; Vandeputte J; Pensaert MB; Leunen J
    Am J Vet Res; 1982 May; 43(5):760-3. PubMed ID: 6283963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
    McCaw MB; Xu J
    Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
    Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
    Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response of sows and their offspring to pseudorabies virus: serum neutralization response to vaccination and field virus challenge.
    Wright JC; Thawley DG; Solorzano RF
    Can J Comp Med; 1984 Apr; 48(2):184-91. PubMed ID: 6326982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams.
    Mengeling WL
    Am J Vet Res; 1989 Oct; 50(10):1658-66. PubMed ID: 2552871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.
    Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK
    Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding patterns in swine of virulent and attenuated pseudorabies virus.
    Maes RK; Kanitz CL; Gustafson DP
    Am J Vet Res; 1983 Nov; 44(11):2083-6. PubMed ID: 6316822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on immunity to Aujeszky's disease (pseudorabies) virus infection in pigs.
    McFerran JB
    Dev Biol Stand; 1975; 28():563-70. PubMed ID: 165131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.
    Brockmeier SL; Lager KM; Tartaglia J; Riviere M; Paoletti E; Mengeling WL
    Vet Microbiol; 1993 Dec; 38(1-2):41-58. PubMed ID: 8128602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows.
    Andries K; Pensaert MB; Vandeputte J
    Am J Vet Res; 1978 Aug; 39(8):1282-5. PubMed ID: 211882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.